References
- Pastore G, Magnani C, Verdecchia A, Pession A, Viscomi S, Coebergh J W. Survival of childhood lymphoma in Europe, 1978 – 1992: a report from the EUROCARE study. Eur J Cancer 2001; 37: 703–710
- Radford J A, Cowan R A, Flanagan M, et al. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol 1998; 6: 940–946
- Luker G D, Siegel M J. Mediastinal Hodgkin disease in children: response to therapy. Radiology 1993; 189: 737–740
- Borgwardt L, Larsen H J, Pedersen K, Hojgaard L. Practical use and implementation of PET in children in a hospital PET center. Eur J Nucl Med Mol Imaging 2003; 30: 1389–1397
- Yeung H, Grewal R K, Gonen M, Schoder H, Larson S M. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 2003; 44: 1789–1796
- Depas G, De Barsy C, Jerusalem G, Hoyoux C, Dresse M F, Fassotte M F, et al. 18F-FDG PET in children with lymphomas. Eur J Nucl Mol Imaging 2005; 32: 31–38
- Hernandez-Pampaloni M, Takalkar A, Yu J Q, Zhuang H, Alavi A. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatr Radiol 2006; 36: 524–531
- Kaste S C, Howard S C, McCarville E B, Krasin M J, Kogos P G, Hudson M M. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Pediatr Radiol 2005; 35: 141–154
- Brink I, Reinhardt M J, Hoegerle S, Altehoefer C, Moser E, Nitzsche E U. Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med 2001; 42: 591–595
- Weinblatt M E, Zanzi I, Belakhlef A, Babchyck B, Kochen J. False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease. J Nucl Med 1997; 38: 888–890
- Kawano T, Suzuki A, Ishida, et al. The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy. Eur J Nucl Med Mol Imaging 2004; 31: 831–836
- Shin M S, Ho K J. Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin's disease. An immunologic rebound phenomenon?. Cancer 1983; 51: 30–33
- Asad S, Aquino S L, Piyavisetpat N, Fischman A J. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. Am J Roentgenol 2004; 182: 983–989